When good cholesterol goes bad
- 1 September 2004
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 10 (9) , 902-903
- https://doi.org/10.1038/nm0904-902
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Oral D-4F Causes Formation of Pre-β High-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null MiceCirculation, 2004
- Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDLJournal of Lipid Research, 2004
- Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL CholesterolNew England Journal of Medicine, 2004
- Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin TreatmentCirculation, 2003
- Prognostic Value of Myeloperoxidase in Patients with Chest PainNew England Journal of Medicine, 2003
- Association of Nitrotyrosine Levels With Cardiovascular Disease and Modulation by Statin TherapyJAMA, 2003
- Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma CholesterolCirculation, 2002
- Increased Immunolocalization of Paraoxonase, Clusterin, and Apolipoprotein A-I in the Human Artery Wall With the Progression of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1997